coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Prestwich PCN, Bury (LAD) · Health Inequalities Profile

    PCN U73478 · NHS Greater Manchester Integrated Care Board · 6 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    40,576

    Registered population

    59.8% aged 18–64

    16.2%

    Aged 65+

    ICB 14.9% · England 17.9%

    20.1%

    Ethnic minority (non-White)

    9.5% Asian · England 9.6%

    13.3%

    In IMD quintile 1

    ICB 40.7% · England 21.0%

    ~5,034

    Core20 residents (est.)

    Resident basis; registered basis ~5,111 · see page 3

    5,360

    Hypertension register

    +6.35% in 3 yrs · England +5.60%

    489

    SMI register

    19.6% of Bury (LAD)'s

    565

    COPD register

    Reviews -3.16% in 3 yrs

    Forecast to 2030

    6,127

    Hypertension patients, 2030

    +767 on today

    67.4%

    QRISK ≥20% on statins, 2030

    +2.79pp over 3 yrs

    3.9%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    -5.0%
    Heart failure and COPD reviews fell over 2023-2025.

    Over 2023 to 2025, heart failure reviews fell 5.0% (England +8.7%) and COPD reviews fell 3.2% to 73.1% (England +2.8%, 76.4%), suggesting recall gaps.

    61.4%
    High-risk lipid therapy trails ICB and England.

    Lipid-lowering therapy for QRISK ≥ 20% is 61.4%, below Bury (LAD) (64.2%), NHS Greater Manchester Integrated Care Board (67.0%) and England (63.6%).

    +12.2 pp
    Three-year SMI physical health checks outpaced England.

    Over 2023 to 2025, SMI BMI recording rose +12.2 pp to 82.4% (England +5.1 pp) and blood pressure checks rose +10.7 pp to 83.4%.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Prestwich serves a younger registered population alongside high severe mental illness prevalence

    Prestwich PCN registers 40,576 patients. The network is younger than average: 24.0% (9,753 patients) are aged 0-17, compared with 21.1% in Bury (LAD), 21.8% in NHS Greater Manchester Integrated Care Board and 19.6% in England. Patients aged 65+ comprise 16.2% (6,579 patients; England 17.9%, Bury (LAD) 17.6%, ICB 14.9%). Census usual-resident estimates indicate 20.1% are from ethnic minority groups, including 9.5% Asian / Asian British (England 9.6%, Bury (LAD) 10.6%, ICB 13.6%) and 4.5% Other ethnic group (England 2.2%, Bury (LAD) 1.9%, ICB 2.3%). Population growth to 2030 is projected at 0.8% with unverified methodology.

    Age profile

    0–1724.0%
    18–6459.8%
    65+16.2%

    65+: ICB 14.9%, England 17.9%

    Ethnicity

    White79.9%
    Asian9.5%
    Other4.5%
    Mixed3.1%
    Black2.9%

    Older people · falls rows are Bury (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Bury LA)2,1392,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)84.4%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)60.5%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Bury LA)1,0511,0219552024/25
    Falls deaths, all ages, per 100,000 (Bury LA)21.818.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Overall PCN Core20 deprivation is 13.3% and concentrates sharply across member practices

    Prestwich PCN's Core20 share is 13.3%, below Bury (LAD) at 27.9%, NHS Greater Manchester Integrated Care Board at 40.7%, and England at 21.0%. Average IMD decile is 5.0. Weighted practice Core20 share is 12.60% (a 0.67 percentage point discrepancy). Deprivation concentrates at St Gabriel's Medical Centre (28.99% share; 2,544 estimated patients), while Fairfax Group Practice accounts for the largest volume (8.22% share; 1,167 estimated patients). Preventive capacity should balance intensive outreach at St Gabriel's Medical Centre with scalable interventions at Fairfax Group Practice.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    St Gabriel's29.0% · 2,544 patients
    Longfield Medical11.2% · 516 patients
    Birches10.9% · 417 patients
    Fairfax8.2% · 1,167 patients
    Whittaker Lane6.3% · 467 patients
    Greyland0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    489

    SMI register

    1.18% recorded prevalence

    235

    Learning disability register

    0.57% recorded prevalence

    21

    Care homes, 773 beds

    In the PCN catchment

    9.4%

    Provide unpaid care

    Bury (LAD), Census 2021

    The PCN records 489 patients with severe mental illness (1.2% prevalence, compared with 1.2% in Bury (LAD), 1.1% in NHS Greater Manchester Integrated Care Board and 1.0% in England) and 235 on the learning disability register (0.6% across all comparators). The catchment also contains 21 care homes with 773 beds. Higher severe mental illness prevalence than England and substantial care-home capacity require sustained proactive review workloads.

    Severe mental illness: physical health checks

    Recorded severe mental illness prevalence is 1.2% (England 1.0%). Annual physical checks reached 83.4% for blood pressure (England 83.4%) and 82.4% for BMI (England 82.1%).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    5,360

    Hypertension register

    +6.35%

    Register growth, 3 yrs

    Bury (LAD) +6.10% · England +5.60%

    +4.48pp

    BP control, under 80

    ≤140/90 · +5.23pp aged 80+

    +767

    More patients by 2030

    Forecast 6,127 (14.67%)

    Hypertension case-finding and control

    Hypertension QOF prevalence is 13.0% (5,360 patients), below Bury (LAD) (15.2%), NHS Greater Manchester Integrated Care Board (14.4%) and England (15.2%), indicating a modelled crude gap of +794 to +820 patients that is not age-adjusted. Over 2023 to 2025, prevalence grew +6.3% (England +5.6%). Process delivery is stable: 89.7% of hypertensive patients had a recent blood pressure check (Bury (LAD) 88.8%, England 90.0%), and 70.6% were treated to target, exceeding England (70.3%) and matching Bury (LAD) (70.7%). Lower crude prevalence alongside strong treatment control suggests opportunistically checking unrecorded blood pressure readings could identify missing diagnoses.

    Lipids and statins

    At 61.4%, lipid-lowering therapy for patients with QRISK ≥ 20% trails England (63.6%), Bury (LAD) (64.2%) and NHS Greater Manchester Integrated Care Board (67.0%). In 2026, lipid-regulating prescribing reached 1,557 items per 1,000 adults aged 18 and over, below England (4,100 rate), Bury (LAD) (2,245 rate) and the ICB (2,298 rate).

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202648,000£2.20£1.94£1.86£105,600
    Cardiovascular (all), 202567,421£3.48£3.15£3.33£234,625

    In 2026, the PCN prescribed 48,000 lipid-regulating items at £2.20 per item (England £1.86, Bury (LAD) £1.91, NHS Greater Manchester Integrated Care Board £1.94), spending £16,320 more than at England's unit cost across 48,000 items. Unit cost differences provide context for local formulary and prescribing reviews.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +7.70%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −1.94%

    Asthma prevalence, PCN 3-yr % change

    COPD prevalence is 1.4% (565 patients), below Bury (LAD) (2.1%) and England (1.9%), having fallen -1.7% over 2023 to 2025 (England +2.6%). Annual COPD reviews fell -3.2% to 73.1% (England +2.8% to 76.4%, Bury (LAD) 77.8%). Asthma prevalence is 6.4% (2,456 patients; England 6.6%), with 12-month reviews at 64.1% (England 65.7%), leaving about 880 patients without a recorded review.

    Cancer register and children's immunisation

    Cancer prevalence is 3.3% (1,367 patients vs 3.8% in England). In Q1 2025/26 childhood immunisations, age-5 MMR dose 1 reached 95.5% (England 91.7%), exceeding the 95.0% target. However, MMR dose 2 fell to 91.0% (a 4.5 pp dose difference) and the 4-in-1 booster reached 88.3%, trailing the 95.0% target by 6.7 pp. Pre-school booster attrition leaves an under-protected cohort requiring coordinated practice recall before primary school entry.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months89.6%

    England 91.0%

    6-in-1 complete primary course at 24 months93.4%

    England 92.2%

    MMR dose 1 at 24 months91.5%

    England 88.3%

    MMR dose 2 at age 591.0%

    England 82.8%

    4-in-1 pre-school booster at age 588.3%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Greater Manchester ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,270

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Greater Manchester ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%15%2,193
    Prostate61.7%53.2%14%1,788
    Breast82.5%85.4%19%1,758
    Bowel46.3%47.0%19%1,427
    Skin cancer84.5%87.8%27%580

    In 2022, NHS Greater Manchester ICB recorded 55.6% of known-stage cancers diagnosed at stage 1 or 2 (6,491 of 11,679), in line with England (55.3%) but 19.4 pp below the 75.0% national ambition. Known stage was recorded for 70.8% of registrations (11,679 of 16,492). Across Prestwich PCN, cervical screening reached 71.7% (England 66.8%), but practice coverage was 59.1% at St Gabriel's Medical Centre and 64.6% at Greyland Medical Centre. Uneven screening uptake leaves underserved cohorts at greater risk of late presentation.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026, Manchester University NHS Foundation Trust achieved 72.8% on the 62-day cancer standard, 12.2 pp below the 85.0% standard, compared with 78.6% at Northern Care Alliance NHS Foundation Trust, 69.7% at Bolton NHS Foundation Trust, 75.7% across NHS Greater Manchester ICB, and 71.2% nationally. The 28-day faster diagnosis standard reached 80.1% (Northern Care Alliance 75.2%, England 79.3%). Diagnostic 6-week waits at Manchester University NHS Foundation Trust were 11.7% for MRI and 13.0% for cystoscopy (Northern Care Alliance 0.0%). Treatment delays at acute providers could prolong diagnostic intervals for referred PCN patients.

    Pathways within standard (%)ManchesterNorthern Care AllianceBoltonGreater Manchester ICBEngland
    28-day faster diagnosis (75%)80.0675.2080.4879.5379.32
    31-day treatment (96%)92.5494.5496.5096.4992.50
    62-day referral to treatment (85%)72.8578.6569.6675.7371.16
    Diagnostic waits over 6 weeks (%)ManchesterNorthern Care AllianceBoltonEngland
    MRI11.685.092.0521.40
    CT14.664.1019.409.92
    Echocardiography4.9131.483.4828.48
    Colonoscopy4.5140.041.3330.83
    Gastroscopy29.3536.482.0629.02
    All 15 DM01 tests8.9815.7115.7823.14
    Community services activityBury residentsGreater Manchester ICB
    Care contacts58,875573,310
    Referrals7,43594,470
    Patients with a contact16,745183,535

    Community services (residents of Bury), Jun 2026 (provisional). In June 2026, provisional community services data showed 43.7% of contacts for Bury borough residents were with adults aged 65 and over (25,735 of 58,875 total contacts). High community service contact among older residents highlights an important touchpoint for supportive and palliative care.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice variation and patient experience

    In 2025/26, QOF overall achievement ranged from 44.6% at Greyland Medical Centre to 98.0% at Whittaker Lane Med Centre; St Gabriel's Medical Centre achieved 92.5%, matching the England average of 92.5%. Vaccination and immunisation achievement showed a 66.7 pp spread, from 15.6% at Greyland Medical Centre to 82.3% at Whittaker Lane Med Centre.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Birches13310.979.4%72.2%89.7%
    Greyland850.090.1%66.3%76.9%
    Fairfax1258.252.0%82.6%73.4%
    St Gabriel's11029.060.4%47.7%68.3%
    Longfield Medical10011.235.9%62.9%67.1%
    Whittaker Lane1056.327.9%61.0%58.9%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNBury (LAD)AssetPCNBury (LAD)
    Care homes (catchment)21 (773 beds)n/aSchools (catchment)75n/a
    Children's centres38Places of worship54107
    Libraries312Primary schools (LA maintained)725
    Primary academies1033Special schools11

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Hypertension case-finding and record audit

    Hypertension QOF prevalence is 13.0% (5,360 patients) vs 15.2% in Bury (LAD) and 15.2% in England: a crude gap of +794 to +820 patients. For discussion: run an electronic search for patients with repeated raised blood pressure readings without a hypertension code, alongside opportunistic checks at Core20 practices. Low cost, quick to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 2

    COPD review recall and register validation

    COPD prevalence is 1.4% (565 patients vs 2.1% in Bury (LAD) and 1.9% in England; +204 to +267 gap), while reviews fell 3.2% to 73.1%. For discussion: establish structured annual review recall for existing COPD patients and audit records of smokers with repeated respiratory prescribing lacking a diagnostic code. Moderate effort to run.

    Evidence base: the copd register is the cohort for spirometry-confirmed diagnosis, annual review and inhaler technique; register size and growth set the workload those interventions must cover.

    Policy anchor: Core20PLUS5 adults: chronic respiratory disease (COPD vaccination and exacerbation reduction); Tobacco and Vapes Bill: smokefree generation.

    Option 3

    Heart failure review and register audit

    Heart failure prevalence is 0.9% (381 patients vs 1.2% in Bury (LAD) and 1.1% in England; +65 to +110 gap); reviews fell 5.0% to 78.0%. For discussion: audit hospital discharge summaries for uncoded heart failure and standardise annual review templates so functional capacity assessments are consistently captured. Moderate effort to run.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Targeted Core20 outreach strategy (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Severe mental illness check maintenance (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension electronic record audit (p5)Hypertension: QOF prevalenceCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school immunisation catch-up recall (p6)4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening equity outreach (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Option 1 · Hypertension case-finding and record audit (p12)Hypertension register · Hypertension: QOF prevalence · Hypertension patients treated to targetCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Option 2 · COPD review recall and register validation (p12)COPD register · COPD: QOF prevalence · COPD patients with a review in the last 12 monthsCore20PLUS5 approach · Tobacco and Vapes BillPCN
    Option 3 · Heart failure review and register audit (p12)Heart failure register · Heart Failure: QOF prevalence · Patients with heart failure who had a review in the last 12 months including the assessment of functional capacity (denominator incl. PCAs)—PCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15